Skip to main content

Date last updated: 10/06/2021

 

General comments:  We provide these summary data in the spirit of transparency and open data sharing.  Given the relatively small number of reported cases and preliminary nature of these reports, we do not recommend these data be used to inform clinical decisions at this time. Additionally, as many mild cases of COVID-19 do not undergo testing, these data may over-represent more severe cases in which COVID-19 testing was performed. Please note that rows and columns from tables below may not add up to the exact number of total reported cases due to incomplete data and/or non-mutually exclusive variables.

Please use the following citation if referencing the data on this page: Brenner EJ, Ungaro RC, Colombel JF, Kappelman MD. SECURE-IBD Database Public Data Update. covidibd.org. Accessed on MM/DD/YY.

 

Total number of cases reported: 6,635

 

Report a Case

Cases reported by country*

countryN
United States2320
United Arab Emirates20
Afghanistan1
Argentina97
Austria134
Australia20
Belgium178
Bulgaria35
Bahrain1
Saint Barthélemy1
Bolivia, Plurinational State of1
Brazil144
Canada199
Switzerland44
Chile38
China1
Colombia3
Costa Rica4
Cyprus4
Czech Republic60
Germany222
Denmark1
Dominican Republic16
Ecuador4
Egypt3
Spain500
Finland7
France131
United Kingdom237
Greece84
Croatia26
Hungary6
Ireland89
Israel45
India39
Iran, Islamic Republic of59
Italy188
Japan84
Korea, Republic of3
Kuwait24
Kazakhstan1
Lebanon3
Luxembourg1
Latvia10
Morocco8
Moldova, Republic of14
Mexico28
Malaysia3
Netherlands358
Norway19
Nepal1
New Zealand1
Peru10
Philippines6
Poland53
Portugal133
Paraguay1
Qatar2
Romania16
Serbia15
Russian Federation496
Saudi Arabia14
Sweden2
Slovenia16
Slovakia104
Tunisia2
Turkey127
Ukraine4
Uruguay9
Venezuela, Bolivarian Republic of4
South Africa17
Missing84

* Countries not included in this table have not reported any cases to SECURE-IBD

 

Cases reported by state (U.S. only)*

stateN
ALABAMA24
ARIZONA20
ARKANSAS14
CALIFORNIA130
COLORADO17
CONNECTICUT31
DELAWARE4
DISTRICT OF COLUMBIA10
FLORIDA107
GEORGIA66
IDAHO9
ILLINOIS199
INDIANA14
IOWA23
KANSAS15
KENTUCKY14
LOUISIANA45
MAINE2
MARYLAND48
MASSACHUSETTS67
MICHIGAN50
MINNESOTA81
MISSISSIPPI29
MISSOURI46
MONTANA12
NEBRASKA47
NEVADA6
NEW HAMPSHIRE3
NEW JERSEY84
NEW MEXICO1
NEW YORK301
NORTH CAROLINA81
NORTH DAKOTA3
OHIO146
OKLAHOMA10
OREGON12
PENNSYLVANIA97
RHODE ISLAND24
SOUTH CAROLINA22
SOUTH DAKOTA3
TENNESSEE62
TEXAS91
UTAH19
VERMONT3
VIRGINIA48
WASHINGTON38
WEST VIRGINIA1
WISCONSIN63
GUAM2
PUERTO RICO6
NA70

* States not included in this table have not reported any cases to SECURE-IBD

 

Cases and outcomes by patient characteristics

CharacteristicTotal NOutpatient only (n, %) Hospitalized (n, %) ICU (n, %) Ventilator (n, %) Death (n, %) ICU/Ventilator/Death (n, %) 
Overall6,6355,55284%99615%1873%1442%1052%2634%
Age
0-9 years 413790%37%25%25%00%25%
10-19 years 70766794%314%61%20%00%61%
20-29 years 1,3681,25091%1038%40%10%10%50%
30-39 years 1,3811,22689%13310%161%81%40%171%
40-49 years 1,1851,01085%16414%262%182%40%292%
50-59 years 1,00578278%21521%434%414%141%606%
60-69 years 54335365%17833%5510%458%285%6612%
70-79 years 22612354%9843%2612%198%2411%4118%
>=80 years 1406949%6748%75%86%2921%3525%
Sex
Male 3,1892,59581%55717%1013%782%722%1505%
Female 3,3342,86286%42613%832%632%331%1103%
Other 3267%00%00%00%00%00%
Disease type
Crohn’s disease 3,8003,27886%47513%802%662%471%1133%
Ulcerative Colitis/unspecified2,7912,24080%51518%1054%763%572%1485%
IBD Disease
Activity
Remission3,6833,17686%48313%943%772%501%1354%
Mild1,4111,20886%18413%302%222%201%453%
Moderate/Severe1,20990975%28323%534%373%292%716%
Unknown33225978%4614%103%82%62%124%
Smoking
Current smoker26622283%4417%62%21%52%93%
Non-smoker6,3695,33084%95215%1813%1422%1002%2544%
Comorbidities
04,7394,24290%4459%551%401%100%681%
11,3131,01377%27421%514%383%292%695%
236121560%14039%3510%339%247%5315%
3+2228237%13762%4621%3315%4219%7333%
IBD medication
Sulfasalazine/mesalamine1,9781,54378%41621%824%704%533%1196%
Budesonide 17813676%4123%95%53%63%127%
Oral/parenteral steroids 42126463%14935%4210%307%287%5413%
6MP/azathioprine monotherapy57245279%11620%275%173%112%346%
Methotrexate monotherapy513773%1325%12%12%36%48%
Anti-TNF without 6MP/AZA/MTX 2,1571,94890%1869%251%181%100%332%
Anti-TNF + 6MP/AZA/MTX 65755584%9214%173%122%61%213%
Anti-integrin 71961085%9613%223%112%91%294%
IL 12/23 inhibitor 61755390%518%91%81%51%112%
JAK inhibitor 1059187%1211%44%11%11%44%
Other IBD medication 21316778%4320%94%52%42%94%

*Medication categories are not mutually exclusive

 

Please use the following citation if referencing the data on this page: Brenner EJ, Ungaro RC, Colombel JF, Kappelman MD. SECURE-IBD Database Public Data Update. covidibd.org. Accessed on MM/DD/YY.